Gast ::
| Hauptseite > Workflowsammlungen > Öffentliche Einträge > QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers > print |
| Hauptseite > Workflowsammlungen > Öffentliche Einträge > QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers > print |
| 001 | 276568 | ||
| 005 | 20220930130051.0 | ||
| 024 | 7 | _ | |a 10.1038/srep13222 |2 doi |
| 024 | 7 | _ | |a 2128/9555 |2 Handle |
| 024 | 7 | _ | |a WOS:000361591400001 |2 WOS |
| 024 | 7 | _ | |a altmetric:4624062 |2 altmetric |
| 024 | 7 | _ | |a pmid:26394756 |2 pmid |
| 037 | _ | _ | |a FZJ-2015-06933 |
| 082 | _ | _ | |a 000 |
| 100 | 1 | _ | |0 P:(DE-HGF)0 |a Brener, Oleksandr |b 0 |
| 245 | _ | _ | |a QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers |
| 260 | _ | _ | |a London |b Nature Publishing Group |c 2015 |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1457697908_319 |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 336 | 7 | _ | |2 DRIVER |a article |
| 520 | _ | _ | |a Strong evidence exists for a central role of amyloid β-protein (Aβ) oligomers in the pathogenesis of Alzheimer’s disease. We have developed a fast, reliable and robust in vitro assay, termed QIAD, to quantify the effect of any compound on the Aβ aggregate size distribution. Applying QIAD, we studied the effect of homotaurine, scyllo-inositol, EGCG, the benzofuran derivative KMS88009, ZAβ3W, the D-enantiomeric peptide D3 and its tandem version D3D3 on Aβ aggregation. The predictive power of the assay for in vivo efficacy is demonstrated by comparing the oligomer elimination efficiency of D3 and D3D3 with their treatment effects in animal models of Alzheimer´s disease. |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-553 |a 553 - Physical Basis of Diseases (POF3-553) |c POF3-553 |f POF III |x 0 |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-581 |a 581 - Biotechnology (POF3-581) |c POF3-581 |f POF III |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |0 P:(DE-Juel1)145867 |a Dunkelmann, Tina |b 1 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)145165 |a Gremer, Lothar |b 2 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a van Groen, Thomas |b 3 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Mirecka, Ewa A. |b 4 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Kadish, Inga |b 5 |
| 700 | 1 | _ | |0 P:(DE-Juel1)144347 |a Willuweit, Antje |b 6 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)159137 |a Kutzsche, Janine |b 7 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)144626 |a Jürgens, Dagmar |b 8 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)144116 |a Rudolph, Stephan |b 9 |
| 700 | 1 | _ | |0 P:(DE-Juel1)131709 |a Tusche, Markus |b 10 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)138895 |a Bongen, Patrick |b 11 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)128906 |a Pietruszka, Jörg |b 12 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Oesterhelt, Filipp |b 13 |
| 700 | 1 | _ | |0 P:(DE-Juel1)131777 |a Langen, Karl-Josef |b 14 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Demuth, Hans-Ulrich |b 15 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Janssen, Arnold |b 16 |
| 700 | 1 | _ | |0 P:(DE-Juel1)166306 |a Hoyer, Wolfgang |b 17 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Funke, Susanne A. |b 18 |
| 700 | 1 | _ | |0 P:(DE-Juel1)162443 |a Nagel-Steger, Luitgard |b 19 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)132029 |a Willbold, Dieter |b 20 |e Corresponding author |u fzj |
| 773 | _ | _ | |0 PERI:(DE-600)2615211-3 |a 10.1038/srep13222 |g Vol. 5, p. 13222 - |p 13222 |t Scientific reports |v 5 |x 2045-2322 |y 2015 |
| 856 | 4 | _ | |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585794/ |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/276568/files/QIAD%20assay%20for%20quantitating%20a%20compound%E2%80%99s%20efficacy%20in%20elimination%20of%20toxic%20A%CE%B2%20oligomers_2015.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/276568/files/QIAD%20assay%20for%20quantitating%20a%20compound%E2%80%99s%20efficacy%20in%20elimination%20of%20toxic%20A%CE%B2%20oligomers_2015.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:276568 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)145867 |a Forschungszentrum Jülich GmbH |b 1 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)145165 |a Forschungszentrum Jülich GmbH |b 2 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)144347 |a Forschungszentrum Jülich GmbH |b 6 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)159137 |a Forschungszentrum Jülich GmbH |b 7 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)144626 |a Forschungszentrum Jülich GmbH |b 8 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)131709 |a Forschungszentrum Jülich GmbH |b 10 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)138895 |a Forschungszentrum Jülich GmbH |b 11 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)128906 |a Forschungszentrum Jülich GmbH |b 12 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)131777 |a Forschungszentrum Jülich GmbH |b 14 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)166306 |a Forschungszentrum Jülich GmbH |b 17 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)162443 |a Forschungszentrum Jülich GmbH |b 19 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)132029 |a Forschungszentrum Jülich GmbH |b 20 |k FZJ |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-553 |1 G:(DE-HGF)POF3-550 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |v Physical Basis of Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-581 |1 G:(DE-HGF)POF3-580 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l Key Technologies for the Bioeconomy |v Biotechnology |x 1 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
| 915 | _ | _ | |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |a Creative Commons Attribution CC BY 4.0 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1040 |2 StatID |a DBCoverage |b Zoological Record |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b SCI REP-UK : 2014 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0500 |2 StatID |a DBCoverage |b DOAJ |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0510 |2 StatID |a OpenAccess |
| 915 | _ | _ | |0 StatID:(DE-HGF)9905 |2 StatID |a IF >= 5 |b SCI REP-UK : 2014 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)ICS-6-20110106 |k ICS-6 |l Strukturbiochemie |x 0 |
| 920 | 1 | _ | |0 I:(DE-Juel1)IBOC-20090406 |k IBOC |l Institut für Bioorganische Chemie (HHUD) |x 1 |
| 920 | 1 | _ | |0 I:(DE-Juel1)IBG-1-20101118 |k IBG-1 |l Biotechnologie |x 2 |
| 980 | 1 | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a I:(DE-Juel1)IBOC-20090406 |
| 980 | _ | _ | |a I:(DE-Juel1)IBG-1-20101118 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a APC |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| 981 | _ | _ | |a I:(DE-Juel1)IBOC-20090406 |
| 981 | _ | _ | |a I:(DE-Juel1)IBG-1-20101118 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|